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Abstract
The plasma membrane Ca2+-ATPases (PMCA) represent the major high-affinity Ca2+ extrusion
system in the brain. PMCAs comprise four isoforms and over 20 splice variants. Their different
functional properties may permit different PMCA splice variants to accommodate different kinds of
local [Ca2+] transients, but for a specific PMCA to play a unique role in local Ca2+ handling it must
be targeted to the appropriate subcellular compartment. We used immunohistochemistry to study the
spatial distribution of PMCA2a–one of the two major carboxyl-terminal splice variants of PMCA2–
in the adult rat brain, testing whether this isoform, with especially high basal activity, is targeted to
specific subcellular compartments. In striking contrast to the widespread distribution of PMCA2 as
a whole, we found that PMCA2a is largely restricted to parvalbumin-positive inhibitory presynaptic
terminals throughout the brain. The only major exception to this targeting pattern was in the cerebellar
cortex, where PMCA2a also concentrates postsynaptically, in the spines of Purkinje cells. We
propose that the fast Ca2+ activation kinetics and high Vmax of PMCA2a make this pump especially
suited for rapid clearance of presynaptic Ca2+ in fast-spiking inhibitory nerve terminals, which face
severe transient calcium loads.
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Ca2+ signaling plays a central role in neurons. To regulate different functions independently
within spatially restricted zones, neurons compartmentalize their Ca2+ signals within
microdomains. Thus, within a single neuron characteristic ensembles of Ca2+ channels,
transporters, and binding proteins are found at distinct locations within the soma, axon, and
dendrites (Bootman et al., 2001; Rizzuto, 2001). Growing evidence shows that the plasma
membrane Ca2+-ATPase (PMCA) family of calcium pumps plays an important role in shaping
Ca2+ dynamics in these restricted cellular compartments (Strehler et al., 2007a).
An intriguing feature of the PMCA family is its diversity. In mammals, four PMCA isoforms
are encoded by separate genes. From these four genes, more than 20 distinct PMCAs are
generated through alternative splicing (Strehler and Zacharias, 2001; Di Leva et al., 2008).
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Alternative splicing affects two major regions of the protein: the first intracellular loop (site
A), and the C-terminal tail (site C), which includes sites for phosphorylation by protein kinases
A and C. Calmodulin binding to the C-tail regulates the activity of the pump. In its absence,
the C-tail acts as an autoinhibitory domain of the pump (Penniston et al., 1988). When
calmodulin binds, the C-tail dissociates from the catalytic core, thus activating the pump.
The main splice variants generated at the C-terminal site (termed “a” and “b”) differ in their
primary amino acid sequence due to a change in reading frame. Functionally, the most notable
consequence of C-terminal splicing is a difference in calmodulin and kinase regulation, leading
to different kinetics of calmodulin and Ca2+ activation of these pumps (Penniston and Enyedi,
1998).
The large number of functionally different PMCAs raises the possibility that specific PMCA
variants are optimized for different kinds of [Ca2+] transients (Domi et al., 2007). Different
PMCAs may help shape slow tonic Ca2+ in some cells and provide rapid Ca2+ clearance in
others (Strehler et al., 2007b). Consistent with this idea, PMCA isoforms show developmental-,
tissue-, and cell-specific patterns (Kip et al., 2006). PMCA isoforms are differentially
expressed among different regions of the adult brain, and among different classes of neurons
within a single brain region (Burette et al., 2003). Moreover, neurons can restrict PMCA
expression to specific subcellular compartments. For example, we recently demonstrated that
in cerebellar Purkinje cells, PMCA2 (the main PMCA isoform in the brain) concentrates in
dendritic spines (Burette and Weinberg, 2007). Analogously, individual splice variants might
be selectively distributed. Such organization could be functionally important, since different
C-terminal splice variants of individual PMCA isoforms vary in their basal activity, kinetics,
and regulation by modulatory proteins, but little empirical evidence for splice variant
specificity is yet available.
Here, we used immunohistochemistry to investigate the spatial distribution of the “a” variant
of PMCA2 (PMCA2a) in the adult rat brain, testing whether this splice variant is targeted to
specific neuronal compartments. We found that PMCA2a concentrates in parvalbumin-positive
inhibitory terminals throughout the brain. The only major exception to this targeting pattern
was in the cerebellar cortex, where PMCA2a concentrates postsynaptically in the spines of
Purkinje cells. This exquisitely specific targeting reinforces the idea that the multiplicity of
PMCA splice variants may allow neurons to use the right calcium pump at the right place.
MATERIALS AND METHODS
Antibody characterization
For PMCA2 and PMCA2a the rabbit polyclonal antibodies NR2 and CR2a (Filoteo et al.,
1997) were used, respectively. NR2 was generated against a 15-residue peptide sequence
(TNSDFYSKNQRNESS, residues 5–19) in the amino terminus region of rat PMCA2, and
CR2a was generated against a 20-residue peptide sequence (SLSNALSSPTSLPPAAAGGG,
residues 1149–1168 of PMCA2x/a) in the carboxy terminus region of rat PMCA2a (Filoteo et
al., 1997). The specificity of these antibodies was established by Western blots using
microsomes from COS cells overexpressing specific PMCAs, and further confirmed in
microsomes from rat brain. In both cases, NR2 recognizes two bands at 127 kDa and 132 kDa,
corresponding to PMCA2a and PMCA2b, respectively, while CR2a recognizes only one band
at 127 kDa. Moreover, staining was absent in the presence of corresponding peptide
immunogen (Filoteo et al., 1997). To further verify antibody specificity, we performed
immunocytochemistry on brain sections from deafwaddler-2J allele mutant mice (CByJ.A-
Ttc7+?Atp2b2dfw-2J/J, stock 002894, Jackson Laboratory, Bar Harbor, ME), reported to lack
PMCA2 mRNA and protein (Street et al., 1998), run in parallel with material from control
mice and rats. Staining with both antibodies in the dfw2J mutant mice was extremely weak,
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exhibiting a “background” pattern unrelated to that seen for controls (data not shown). NR2
and CR2a were used at 1:200 for DAB immunocytochemistry and 1:40,000 for
immunofluorescence using tyramide signal amplification.
For VGLUT1, a guinea pig polyclonal anti-VGLUT1 (Chemicon, Temecula, CA; AB5905,
lot 24041061) raised against rat VGLUT1 was used. This antibody was affinity-purified using
the immunogenic peptide. By sequencing the immunogen peptide (Chemicon, AG208), we
found that this antibody was raised against a C-terminus peptide
(GATHSTVQPPRPPPPVRDY, Melone et al., 2005). This antibody recognizes a single band
of Mr ≈60,000 on immunoblots of synaptic membrane fractions from rat cerebral cortex.
Furthermore, immunogold labeling shows that VGLUT1 immunoreactivity is selectively
associated with axon terminals forming asymmetric synapses in cerebral cortex and
hippocampus.
For GABA, a rabbit polyclonal anti-GABA (Sigma, St. Louis, MO; A2052, lot 052K4827)
developed using GABA-BSA as the immunogen was used. The antibody was affinity-purified
using the immunogen. It shows positive binding with GABA, and GABA-KLH in a dot blot
assay, and negative binding with bovine serum albumin (BSA) (manufacturer's technical
information).
For parvalbumin, a monoclonal anti-parvalbumin antibody (Sigma, PARV-19, P-3088) was
used. This antibody derived from a hybridoma produced by fusing mouse myeloma cells with
splenocytes from a mouse immunized with purified frog muscle parvalbumin. To control for
specify, we performed immunohistochemistry on tissue from parvalbumin-knockout and
corresponding control mice (gift from Dr. B. Schwaller; University of Fribourg, Switzerland;
see Schwaller et al., 2004). No staining was observed in mice lacking parvalbumin.
Tissue preparation
All procedures related to the care and treatment of animals were in accordance with institutional
and NIH guidelines. Twelve male Sprague–Dawley rats (200–350 g, Charles River, Raleigh,
NC) were used for this study. After inducing deep anesthesia with sodium pentobarbital (60
mg/kg, i.p.), rats were intracardially perfused with heparinized saline followed by 500 mL of
fixative. Rats were fixed with 4% paraformaldehyde freshly depolymerized in phosphate buffer
(PB, 0.1 M, pH 7.4) for light microscopy (LM), or with a mixture of 4% paraformaldehyde
and 0.1% glutaraldehyde in PB for EM. Brains were then removed and postfixed for 2 hours
at 4°C in the same fixative. Brains were cut at 40–60 μm on a Vibratome and collected in cold
PB.
Single labeling
Free-floating sections were permeabilized with 50% ethanol for 30 minutes and then treated
for 30 minutes with 3% H2O2 in phosphate-buffered saline (PBS, 0.1 M, pH 7.4). After pre-
incubation in 10% normal donkey serum (NDS, to block secondary antibody binding sites),
sections were incubated in primary antibody overnight on a shaker at room temperature. For
immunoperoxidase microscopy, sections were then incubated for 3 hours in biotinylated
secondary antibody (1:200; Jackson ImmunoResearch, West Grove, PA) and for 1 hour in
ExtrAvidin-peroxidase complex (1:5,000; Sigma); peroxidase was histochemically visualized
with diaminobenzidine. Processed sections were mounted on gelatin-coated slides, airdried,
and cleared with xylene before being coverslipped with D.P.X. mountant (BDH Chemicals,
Poole, UK). For immunofluorescence microscopy, immunoreactivity was visualized by
donkey IgG, conjugated to Cy-3 (Jackson ImmunoResearch). Sections were then mounted on
gelatin-coated slides and directly coverslipped with Vectashield (Vector Laboratories,
Burlingame, CA). To control for method specificity, some sections were processed as above,
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except that primary or secondary antibodies were omitted. In all such cases, staining was
completely absent.
Multiple labeling
Tyramide signal amplification (TSA) was used for multiple labeling with primary antibodies
from a single species. Fluorescent staining with the first primary antibody was enhanced with
TSA and conventional fluorescent staining was then performed with the second primary
antibody. We used the primary antibodies at a concentration so low that antigen consistently
failed to be revealed by a conventional fluorophore-conjugated secondary antibody (donkey
antirabbit IgG conjugated to FITC; 1:200 for 3 hours, Jackson), but was still clearly detectable
with TSA. After overnight incubation in primary antibody, sections were reacted for 2 hours
at room temperature with biotinylated secondary antibody (1:200, Jackson). Biotin was
revealed by FITC conjugated to tyramide (TSA direct kit, PerkinElmer LifeScience, Boston,
MA) according to the manufacturer's recommendation. The second primary antibodies were
then applied overnight. Immunoreactivity was visualized by donkey secondary antibody
conjugated to Cy-3 (Jackson). For triple labeling, the third primary antibody (raised in a
different species than the first two primary antibodies) was applied overnight and visualized
by a secondary antibody conjugated to Cy5 (Jackson).
Several control procedures were performed for the multiple labeling with TSA. Omission of
primary or secondary antibodies resulted in the lack of specific staining in the corresponding
channel. Substitution of preimmune serum for primary antibody led to a very weak Nissl-like
pattern of staining. To control for possible crossreaction between the first primary antibody
and the second secondary antibody, the second primary antibody was omitted. In such cases,
no staining was observed on the channel corresponding to the second secondary antibody.
Moreover, we obtained identical results when the order of the first two primary antibodies was
reversed.
Sections were examined with a Leitz DMR microscope (Leica, Wetzlar, Germany). Images
were acquired with a 12-bit cooled charge-coupled device camera (Retiga EX, QImaging,
Canada) coupled to a Macintosh computer or with a Leica SP2 confocal microscope. We used
Corel Draw v. 12 (Ontario, Canada) to sharpen images, adjust brightness and contrast, and
compose final plates.
Electron microscopy
For preembedding EM immunohistochemistry, sections were permeablized with 50% ethanol
for 30 minutes and treated with 1% sodium borohydride for 30 minutes to quench free aldehyde
groups. Sections were then further processed as for DAB immunoperoxidase staining for LM.
Immunoreacted tissue was rinsed in PB, postfixed 1 hour in 1% osmium tetroxide, rinsed in
PB, rinsed in 0.1 M maleate buffer (MB; pH 6), stained en bloc for 1 hour in 1% uranyl acetate
in MB, rinsed, then dehydrated in a graded ethanol series followed by propylene oxide,
infiltrated with a mixture of Epon and Spurr resins, embedded between two sheets of Aclar
plastic supported by glass slides, and polymerized at 60°C for 36–48 hours. Thin sections
mounted on copper grids were counter-stained with 5% uranyl acetate and Sato's lead and
examined on a Philips Tecnai 12 EM (FEI, Hillsboro, OR).
Image analysis
It is difficult to avoid subjective judgments when studying colocalization of puncta. To permit
more objective assessment of our double-stained material, we employed two different
algorithms designed for this purpose. To estimate the percentage of spatial colocalization we
used an algorithm introduced by Costes et al. (2004). First, an intensity threshold (representing
an estimated background) for each channel was automatically determined based on a linear
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least-squares fit of the green and red intensities in the image's cytofluorogram. Pearson's
correlation coefficient (r) for the thresholded images was then calculated (Gonzalez and Wintz,
1987). Costes' approach was implemented in ImageJ (NIH, Bethesda, MD) using the JACoP
plug-in (Bolte and Cordelieres, 2006; Rasband, 1997–2005).
To test whether staining pairs were positively correlated, negatively correlated, or random, we
performed intensity correlation analysis as described by Li et al. (2004). In contrast to standard
spatial colocalization tests, which are in essence binary tests of whether two stains occur in the
same regions, Li et al.'s method focuses on staining intensity, addressing whether the intensity
of staining for the two proteins varies in synchrony. The method involves generating
scatterplots of stain A or stain B against the product of the difference of each pixel A and B
intensity from its respective means, (Ai – Ā) (Bi –B̄). The intensity correlation analysis results
are then presented as a pair of graphs, where the x-axis reflects the covariance of the channel
and the y axis reflects the intensity distribution of the channel. Since the analysis is carried out
separately for each stain, strong dependence of stain A on B in combination with minimal
dependence of B on A can be identified. Distributions that skew to the right indicate positively
correlated staining patterns (where the two pixel staining intensity values vary in synchrony);
ones that are symmetrical about the 0 axis indicate independent staining; and those that skew
to the left indicate negatively correlated staining patterns, where the pixel staining intensity
values vary inversely. Intensity correlation analyses were accomplished with the “Intensity
Correlation Analysis” plug-in in ImageJ (see the ImageJ Web site established by the Wright
Cell Imaging Facility, Toronto Western Research Institute, Ontario, Canada:
www.uhnresearch.ca/wcif).
RESULTS
PMCA2a was detected throughout the brain. Staining was strongest in the cerebellar cortex,
followed by the superior colliculus and the cerebral cortex (Fig. 1A). Little PMCA2a staining
was found in the white matter.
In the spinal cord, PMCA2a staining was detected throughout the gray matter (Fig. 1B).
PMCA2a was present in all layers of the dorsal horn, although sparse in lamina II (Fig. 1C).
At high magnification, staining appeared punctate; thin processes were also lightly stained, but
immunoreactive cell bodies were not seen (Fig. 1D). In the ventral horn, numerous puncta were
seen in the neuropil (Fig. 1E). Unstained cell bodies–the largest likely to represent α-
motoneurons–were enveloped by PMCA2a-immunoreactive puncta, but were themselves
immunonegative (Fig. 1F).
In the cerebellar cortex, PMCA2a concentrated in the molecular layer, with strongest staining
in spines (Figs. 2A,B). Small spiny secondary dendrites were also immunopositive, but large
aspiny primary dendrites were only weakly stained. A thin layer of PMCA2a staining also
covered the somata of Purkinje cells. In the granule cell layer, synaptic glomeruli were stained,
but little or no staining was detected in the granule cells themselves. In the cerebellar nuclei,
large intensely stained puncta were visible in neuropil; staining surrounded immunonegative
neuronal somata (Fig. 2C). Staining was also prominent in vestibular nuclei.
In the superior colliculus, staining was strongest in the superficial gray and other gray layers,
where PMCA2a was organized into vertically oriented bands (Fig. 2D,E). In deep layers,
staining often surrounded unstained somata (Fig. 2F,G). PMCA2a was present throughout the
thalamus (Fig. 3A). Staining concentrated in dense puncta surrounding somata while more
weakly stained fibers were observed in the neuropil (Fig. 3B,C). In the neostriatum, PMCA2a
staining was confined between fascicles, which themselves exhibited little staining (Fig. 3D).
At high magnification, staining was organized into puncta linked by thin processes (Fig. 3E).
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In hippocampus, PMCA2a staining concentrated in the pyramidal cell layer of Ammon's Horn
(Fig. 4A), where numerous positive puncta covered somata of pyramidal neurons (Fig. 4B,C).
Immunopositive puncta were also observed in stratum radiatum and stratum oriens, but at a
much lower density; scattered thin processes were also visible (Fig. 4B,C). In the dentate gyrus,
staining concentrated in stratum granulosum, where positive puncta covered the somata of
numerous granule cells (Fig. 4D). Scattered positive puncta were visible in the hilus and the
stratum moleculare.
In the cerebral cortex, staining was found in the neuropil throughout all layers (Fig. 5A).
Numerous puncta surrounded unstained somata of pyramidal neurons, especially in layers II/
III and V (Fig. 5B). In contrast to our previous work using a pan-PMCA2 antibody, PMCA2a
staining appeared quite restricted (compare Fig. 5A,B with 5C,D). To confirm this impression,
we performed double-labeling for PMCA2a and pan-PMCA2. PMCA2a staining overlapped
with PMCA2 staining throughout the brain (confirming the specificity of the PMCA2a
antibody), but PMCA2a represented only a modest fraction of PMCA2 staining. In cerebral
cortex, colocalization was prominent around the somata of numerous neurons (Fig. 5E). At
high magnification, pyramidal cell somata were covered by a thin layer of PMCA2-positive/
PMCA2a-negative staining, likely representing PMCA2b at the somatic plasma membrane
(inset in Fig. 5E). These pyramidal neurons were surrounded by a peri-somatic net of puncta
double-stained for PMCA2 and PMCA2a.
To reveal the nature of these puncta we performed electron microscopy. PMCA2a
immunoreactivity concentrated in axon terminals making symmetric synapses onto axon initial
segments or somata (Fig. 5F). Reaction product could be diffuse, but it was usually located in
the back of the terminal, away from the synapse. In contrast, axon terminals making symmetric
synapses onto dendrites were generally devoid of staining. Moreover, PMCA2a
immunoreactivity was not observed in axon terminals making asymmetric synapses onto
dendritic spines. Occasionally, we also observed small clumps of PMCA2a reactivity within
cell bodies, associated with the endoplasmic reticulum. We concluded that PMCA2a
concentrated in a subpopulation of inhibitory axon terminals, but not in excitatory terminals.
Results from LM double-labeling experiments for PMCA2a with VGLUT1 (a marker for
excitatory presynaptic terminals) and GABA (a marker for inhibitory presynaptic terminals)
further support this conclusion. Visual inspection revealed little evidence for colocalization of
PMCA2a with VGLUT1, as documented for cerebral cortex in Figure 6A. Neuronal somata
were immunonegative for PMCA2a, but numerous puncta were double-labeled for PMCA2a
and GABA; these could be seen surrounding both GABA-positive and GABA-negative somata
(Fig. 6B). However, not all perisomatic GABAergic puncta were PMCA2a-positive (Fig. 6C).
Taken together, these findings suggest that PMCA2a in cerebral cortex concentrated in a subset
of GABAergic presynaptic terminals, but not in glutamatergic terminals.
At least three groups of GABAergic cells in cerebral cortex contribute to somatic innervation:
parvalbumin fast-spiking cells; cholecystokinin regular-spiking or burst-spiking nonpyramidal
cells; and small VIP regular-spiking or burst-spiking nonpyramidal cells (Kawaguchi and
Kubota, 1998). We performed double-labeling experiments, finding that PMCA2a was
expressed in a large fraction of parvalbumin-positive terminals (Fig. 7); likewise, the majority
of PMCA2a puncta were also immunopositive for parvalbumin. In contrast, dendrites and
somata positive for parvalbumin were mostly negative for PMCA2a. Thus, we conclude that
in cerebral cortex PMCA2a is expressed selectively in axon terminals of fast-spiking
interneurons. PMCA2a was also closely associated with parvalbumin in other parts of the brain.
In many regions of the brain, including hippocampus (Fig. 7B), PMCA2a staining was mostly
restricted to parvalbumin-positive axon terminals. The only obvious exception to this rule was
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in the molecular layer of the cerebellar cortex, where PMCA2a was expressed in the
(parvalbumin-positive) spines of Purkinje cells (Fig. 7C,D).
Since visual inspection is inherently subjective and may lead to misinterpretation, we
performed quantitative image analysis. We used the method of Costes et al. (2004) to estimate
the percentage of colocalization of PMCA2a with other synaptic markers, finding that 92% of
PMCA2a staining in cerebral cortex overlapped with PMCA2, whereas only 3.5% of PMCA2
overlapped with PMCA2a, confirming our visual impression that PMCA2a-stained profiles
represented a small fraction of all PMCA2-positive structures. For this reason, the Pearson's
correlation coefficient for the two channels, although highly significant, was relatively weak
(r = 0.35). Consistent with our impression that PMCA2a was associated with inhibitory
terminals, 83% of PMCA2a staining overlapped with GABA staining, which represented 36%
of the total GABA staining (r = 0.41); in contrast, PMCA2a and VGLUT showed only ≈2%
overlap. Finally, we confirmed the strong relationship between PMCA2a and parvalbumin,
finding that 95% of PMCA2a staining overlapped with parvalbumin staining, which
represented 22% of the total parvalbumin staining (r = 0.55 ± 0.14).
To gain further insight into the pattern of colocalization, raw confocal images were analyzed
using intensity correlation analysis as described by Li et al. (2004). In every region examined,
images from material double-labeled for PMCA2a and PMCA2, GABA, or parvalbumin
exhibited intensity correlation plots skewed toward the upper right quadrant (Fig. 8), implying
that pixels strongly stained for PMCA2a tended also to be positive for the other antigen,
consistent with colocalization. In contrast, images from material double-labeled for PMCA2a
and VGLUT exhibited intensity correlation plots skewed toward the upper left quadrant (Fig.
8D), implying that pixels strongly stained for PMCA2a tended to be negative for VGLUT. In
conclusion, quantitative image analysis confirms that PMCA2a labeling is largely restricted to
parvalbumin-positive inhibitory nerve terminals.
DISCUSSION
Here we show that PMCA2a, a major PMCA2 splice variant, is expressed in parvalbumin-
positive axon terminals. This selective expression supports the view that PMCAs play an active
role in shaping Ca2+ dynamics in restricted cellular compartments (Krizaj and Copenhagen,
1998; Morgans et al., 1998; Yamoah et al., 1998; Usachev et al., 2002; Bautista and Lewis,
2004; Scheuss et al., 2006).
The overall pattern of immunostaining for PMCA2a reported here is generally consistent with
that shown in a recent report (Jensen et al., 2007). However, our data are at variance with their
conclusion that PMCA2a in hippocampus is enriched in excitatory terminals, and regulates
excitatory synaptic transmission. While the basis of this discrepancy is unclear, it may in part
reflect “noisy” immunostaining or ineffective use of image analysis tools. The confirmatory
functional evidence presented in the study by Jensen et al. (2007) relies on a nonspecific
ATPase inhibitor (carboxyeosin) that modulates all PMCAs, and possibly also SERCA and
Na+ pumps (Helmich-de Jong et al., 1986; Skou and Esmann, 1981). In the light of the present
results, we conclude that the reported enhancement of paired-pulse facilitation observed with
carboxyeosin likely reflects an influence on some other PMCA isoform, or perhaps a secondary
effect of the drug.
PMCA targeting
Our laboratory previously showed that neurons can organize PMCA isoforms differentially
into spatially restricted domains (Burette et al., 2003; Burette and Weinberg, 2007). The present
work extends these results, demonstrating that a single splice variant is targeted to a single type
of presynaptic terminal. Recent experimental studies in model systems have shown that
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alternative splicing can play a major role in PMCA targeting. In epithelial cells the A-splice-
site insert regulates PMCA2 targeting to the apical membrane (Chicka and Strehler, 2003).
Those authors showed that the size of the insertion at the A-splice site controls PMCA2 apical
targeting, regardless of the C-terminal cassette; a 45-amino-acid insert at this site (the w-form)
resulted in apical targeting, whereas smaller inserts resulted in basolateral targeting. Other
PMCAs may use different targeting mechanisms. For example, the binding of PMCA4b to
SAP97 (via its PDZ binding domain) may help to retain the Ca2+ pump at the basolateral
membrane in epithelial cells (DeMarco and Strehler, 2001).
Functional implication of PMCA2a in parvalbumin terminals
The axon terminal represents a restricted calcium microdomain where small fluxes can lead to
massive changes in local [Ca2+]i (Lisman et al., 2007). The spatiotemporal characteristics of
this local signal are shaped by the interplay between Ca2+ sources and sinks; control of these
Ca2+ swings is crucial for the release of neurotransmitter, and for activity-dependent changes
in efficacy of transmitter release (Zucker and Regehr, 2002). PMCA has been found in several
types of presynaptic terminals including terminals of chick Edinger–Westphal neurons (Fujii
et al., 1996), calyx-type presynaptic nerve terminals of the chick ciliary ganglion (Juhaszova
et al., 2000), and parallel fiber terminals in cerebellar cortex (Burette and Weinberg, 2007).
The suspicion that PMCAs may play a major role in controlling Ca2+ in the terminal has been
demonstrated directly in several experimental models, including the motor terminal in
Drosophila (Lnenicka et al., 2006), the ribbon synapses of vertebrate photoreceptors (Morgans
et al., 1998; Johnson et al., 2007), and the calyx of Held (Kim et al., 2005).
Synapses can differ markedly in their efficacy and dynamics, in part due to differences in
Ca2+ handling. A variety of functional differences have been documented in the release
machinery used by excitatory versus inhibitory terminals, but even within the population of
GABAergic terminals, abundant evidence points to functional heterogeneity (Freund and
Buzsaki, 1996; McBain and Fisahn, 2001; Somogyi and Klausberger, 2005): In both neocortex
and hippocampus, parvalbumin marks a distinct class of interneurons, the fast-spiking (FS)
basket cells, characterized by high-frequency, nonadapting spike train (Freund and Buzsaki,
1996). Available evidence suggests that FS basket cells may use a specialized Ca2+ toolkit.
Thus, parvalbumin in FS cells helps to curtail Ca2+ transients in their terminals, preventing
asynchronous release and adaptation (Aponte et al., 2008). In contrast, the lack of calcium-
binding proteins in non-FS basket cells may result in prolonged calcium transients at their
synapses after several closely spaced action potentials. Beyond their distinctive content of
calcium buffers, it was recently shown that GABA release from FS basket cells is mediated
exclusively by P/Q-type VDCCs, whereas GABA release from CCK-positive basket cells is
mediated exclusively by N-type VDCC (Hefft and Jonas, 2005). G-protein mediated inhibition
of P/Q type VDCCs is weaker than that of the N-type, and voltage-dependent relief of G-
protein-mediated inhibition is stronger for P/Q-type channels than for N-type channels. Thus,
P/Q-type channels appear especially well suited for repetitive firing at a high and constant rate.
The present data demonstrate that FS terminals express uniquely high levels of PMCA2a.
PMCA2a has enzymatic and regulatory properties that may contribute to functional
optimization of these axon terminals. Splice variants of PMCA2 have significantly lower Kd
values for Ca2+ that other PMCAs, and therefore can extrude Ca2+ to substantially lower levels
than other PMCA isoforms (Elwess et al., 1997). Ensuring low [Ca2+]i at rest is particularly
important in axon terminals: at least one of the Ca2+ binding sites involved in activating the
transmitter release machinery has a Kd of 10 μM; thus, in order for the release sites to recover
fully after activity, local [Ca2+] must be brought to very low resting levels. Likewise, PMCA2
exhibits especially high Vmax, allowing these terminals to recover quickly after bursts of
activity. Moreover, because of its high affinity for CaM, PMCA2 has a slow inactivation rate,
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implying that during ongoing activity, PMCA2 will remain “pre-activated,” able to respond
immediately to the next Ca2+ spike (Hilfiker et al., 1994; Elwess et al., 1997; Caride et al.,
2001). Finally, PMCA2a (unlike other PMCA2 variants) exhibits exceptionally rapid
activation in response to a rise in [Ca2+]i (Caride et al., 2001). All these characteristics make
PMCA2a ideally matched to the Ca2+ handling requirements of parvalbumin terminals,
permitting reliable transmitter release even during sustained high-frequency firing.
The only notable exception to the general pattern of PMCA2a targeting was in the cerebellar
cortex, where PMCA2a was also expressed in the parvalbumin-rich spines of Purkinje cells.
However, like parvalbumin terminal, these spines exhibit exceptionally large Ca2+ transients,
reinforcing the idea that PMCA2a is adapted to function in microdomains requiring rapid
control of especially large Ca2+ transients.
CONCLUSION
The versatility of Ca2+ as an intracellular messenger depends on its spatial and temporal
properties. To create Ca2+-signaling systems with different spatial and temporal properties,
different cells express different components from a large Ca2+-signaling toolkit. The repertoire
of this toolkit is further expanded through alternative splicing. The highly selective expression
of PMCA2a in the terminals of fast-spiking interneurons illustrates this principle,
demonstrating that functionally different axon terminals use different components from that
toolkit to create Ca2+ signaling systems with different spatiotemporal properties.
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Distribution of PMCA2a in the brain and the spinal cord. Low-magnification view of
immunoperoxidase material shows that PMCA2a is widespread throughout the brain (A).
Strongest immunostaining is in cerebellar cortex; superior colliculus and cerebral cortex also
stain strongly. In the spinal cord, PMCA2a is detected throughout the gray matter (B). In the
dorsal horn, PMCA2a is detected in all layers, although immunoreactivity is weak in lamina
II (C). Staining is organized into puncta in the neuropil with thin processes weakly stained
(D). In the ventral horn, numerous PMCA2a-positive puncta are visible, many of which
surround large unstained somata (F, stars in E). CB, cerebellum; CTX, cerebral cortex; CPu,
caudate-putamen; HPF, hippocampal formation; IC, inferior colliculus; MV, medial vestibular
nucleus; OB, olfactory bulb T, thalamus; SC, superior colliculus. Scale bars = 0.5 cm in A;
250 μm in B; 100 μm in C; 25 μm in D,F; 50 μm in E.
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Distribution of PMCA2a in cerebellum and superior colliculus. PMCA2a is present in all layers
of the cerebellar cortex (A), strongest in the molecular layer. Higher-magnification view
reveals that PMCA2a concentrates in spiny dendrites of Purkinje cells, with a thin layer of
staining covering their somata (B). Spines in small distal dendrites were strongly
immunopositive (inset in B). In deep cerebellar nuclei, PMCA2a staining is patchy, and often
surrounds unstained cell bodies (C). PMCA2a is detected in all layers of the superior colliculus
(D). In the superficial gray layer, PMCA2a concentrates in vertically oriented bundles (E); in
deeper layers it surrounds unstained cell bodies (F,G). Scale bars = 50 μm in A; 20 μm in B,E–
G; 5 μm in inset in B; 25 μm in C; 0.5 mm in D.
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Distribution of PMCA2a in the thalamus and neostriatum. PMCA2a is present throughout the
thalamus (A), especially prominent in the parvalbumin-rich reticular nucleus (arrow). Strong
staining outlines somata while weakly stained fibers are in the neuropil (B,C). In the
neostriatum, PMCA2a concentrates in gray matter (D); staining is organized into puncta linked
by thin processes (E). PO, posterior nuclear complex; VB, ventrobasal nuclear complex; RT:
reticular thalamic nucleus Scale bars = 500 μm in A; 25 μm in B,C; 100 μm in D; 10 μm in E.
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Distribution of PMCA2a in hippocampus. Overview of PMCA2a staining hippocampus
formation (A). In CA1 (B) and CA3 (C) staining is strongest in the pyramidal cell layer (PL),
where numerous PMCA2a puncta surround unstained somata. PMCA2a puncta and thin fibers
are scattered throughout stratum oriens (SO) and radiatum (SR). In the dentate gyrus, staining
is strongest in stratum granulosum (SG) where positive puncta covered the somata of numerous
granule cells (D). Scattered positive puncta are visible in the hilus (H) and the stratum
moleculare (SM). Scale bars = 0.5 mm in A; 50 μm in B–D.
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Distribution of PMCA2 and PMCA2a in the cerebral cortex. Both PMCA2 and PMCA2a stain
all layers of the cerebral cortex (A,C) but while PMCA2 is relatively uniformly distributed
(C), PMCA2a is strongest in layers II/III followed by layer V, and weak in layer I (A). Higher
magnification of layer IV shows that PMCA2 is widespread in the neuropil and covers somatic
and dendritic plasma membranes (D). In contrast, PMCA2a is organized into puncta
surrounding unstained somata (B); thin fibers are also weakly positive. Double labeling
confirms that virtually all PMCA2a staining colocalizes with PMCA2 staining (E), whereas a
large fraction of PMCA2 staining is unrelated to PMCA2a, likely reflecting the PMCA2b splice
variant. High magnification shows that the staining around somata of pyramidal neurons is
composed of a thin layer of PMCA2-positive/PMCA2a-negative staining, covered by puncta
positive for both PMCA2 and PMCA2a (arrow, inset in E); these PMCA2a puncta often appear
hollow. Electron microscopy reveals PMCA2a immunoreactivity in axon terminals making
symmetric synapse onto somata (arrows in F1–3). Within these axon terminals, reaction product
was often confined to the back of the terminal, away from the synapse. In contrast, axon
terminals making asymmetric synapses onto dendritic spines (asterisk in F2) or symmetric
synapses onto dendrites (asterisk in F3) are immunonegative. Scale bars = 200 μm in A,C; 25
μm in B,D; 10 μm in E; 2 μm in F1, 0.5 μm in F2, 0.5 μm in F3.
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PMCA2a colocalizes with GABA in a subset of inhibitory nerve terminals. Double
immunofluorescence shows little colocalization of PMCA2a with VGLUT (A) but extensive
colocalization with GABA (B). Colocalization is prominent around somata (asterisks). At
higher magnification, PMCA2a is present in numerous GABA-positive puncta surrounding
somata, but not all GABA-positive puncta are positive for PMCA2a (C). This staining pattern
suggests that PMCA2a is expressed in a subpopulation of GABAergic axon terminals. Scale
bars = 10 μm in A; 25 μm in B; 5 μm in C.
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Colocalization of PMCA2a with parvalbumin. Double labeling reveals extensive
colocalization of PMCA2a with parvalbumin in cerebral cortex (A), hippocampus (B) and
cerebellar cortex (C,D). In cerebral cortex and hippocampus colocalization is most prominent
around cell bodies, presumably in axon terminals. In contrast in the cerebellar cortex,
colocalization concentrates in dendritic spines. Scale bars = 10 μm in A,D; 50 μm in B; 25
μm in C.
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Intensity correlation analysis of PMCA2a colocalization with different synaptic terminal
markers. Analyses are presented as graphs where the x-value [(protein a intensity)–(mean
protein a intensity)] [(protein b intensity)–(mean protein b intensity)] is dependent on
covariance of both channels, and the y-value reflects the intensity distribution of the one of the
two proteins. The color of each point in the graph represents the frequency of pixels that display
those particular values in the graph, from blue (low frequency) to yellow (high frequency).
Pixels with values situated left of the x = 0 line do not colocalize or have inversely correlated
intensities, whereas pixels situated on the right side colocalize (A, for details, see Materials
and Methods). The graph showing PMCA2 with respect to PMCA2a shows two clouds of
points, one close to 0 and another skewed to the right (B), indicating that one fraction of PMCA2
staining is independent of PMCA2a (absence of colocalization) while a second, smaller fraction
is strongly correlated with PMCA2a. In contrast, the plot for PMCA2a with respect to PMCA2
(C) is skewed toward positive values, indicating that most PMCA2a colocalized with PMCA2.
The plot for PMCA2 and VGLUT (D) is skewed toward negative values, indicating an absence
of colocalization. On the other hand, plots for PMCA2a with respect to GABA (E) and
parvalbumin (F–H) are skewed toward positive values, indicating colocalization. Each
scatterplot corresponds to optical sections used for illustrations in Figures 5, 6, and 7: B and
C, Figure 5E; D, Figure 6A; E, Figure 6B, F, Figure 7A; G, Figure 7B; D, Figure 7C. The
scatterplots are from raw confocal images, while contrast and brightness were adjusted in the
final figures.
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